{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:23:05Z","timestamp":1760016185353},"reference-count":48,"publisher":"Impact Journals, LLC","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,5,23]]},"DOI":"10.18632\/oncotarget.16858","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T19:35:07Z","timestamp":1491420907000},"page":"34946-34953","source":"Crossref","is-referenced-by-count":4,"title":["Treatment of esophageal cancer with radiation therapy: a pan-Chinese survey of radiation oncologists"],"prefix":"10.18632","volume":"8","author":[{"given":"Yun","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Medicine and Life Sciences, University of Jinan Shandong Academy of Medical Sciences, Jinan, Shandong, China"},{"name":"Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[{"name":"Graduate Education Center, Shandong Academy of Medical Sciences, Jinan, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wencheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tianjin Cancer Hospital, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiye","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"},{"name":"Division of Epidemiology, Human Genetics and Environmental Sciences, The University of Texas School of Public Health at Houston, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinbo","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,4,5]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/s40064-016-2119-3","article-title":"Potential biomarkers for esophageal cancer","volume":"5","author":"Cai","year":"2016","journal-title":"Springerplus"},{"key":"2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Jemal","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"3","first-page":"703","article-title":"Incidence and trend analysis of esophageal cancer in China","volume":"38","author":"He","year":"2016","journal-title":"Chin J Oncol"},{"key":"4","first-page":"709","article-title":"Mortality and survival analysis of esophageal cancer in China","volume":"38","author":"He","year":"2016","journal-title":"Chin J Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.21037\/cco.2016.07.04","article-title":"Proton beam therapy for the treatment of esophageal cancer","volume":"5","author":"Chuong","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Blaisse","year":"2015","journal-title":"Lancet Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s10147-004-0454-9","article-title":"Chemoradiotherapy for esophageal cancer: current status and perspectives","volume":"9","author":"Ohtsu","year":"2004","journal-title":"Int J Clin Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.2196\/resprot.4320","article-title":"SANO study group. Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol","volume":"4","author":"van Lanschot","year":"2015","journal-title":"JMIR Res Protoc"},{"key":"9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4251\/wjgo.v6.i8.263","article-title":"Esophageal cancer management controversies: Radiation oncology point of view","volume":"6","author":"Yu","year":"2014","journal-title":"World J Gastrointest Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00423-012-1001-1","article-title":"Multimodal treatment of esophageal cancer","volume":"398","author":"Wittekind","year":"2013","journal-title":"Langenbeck Arch Surg"},{"key":"11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13014-016-0589-7","article-title":"Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice","volume":"11","author":"Yu","year":"2016","journal-title":"Radiat Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1088\/0031-9155\/61\/6\/2372","article-title":"A new scheme for real-time high-contrast imaging in lung cancer radiotherapy: a proof-of-concept study","volume":"61","author":"Jia","year":"2016","journal-title":"Phys Med Biol"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Pasquali, Yim, Vohra, Mocellin, Nyanhongo, Marriott, Geh, Griffiths. Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis. Ann Surg. 2016; p. 1.","DOI":"10.1097\/SLA.0000000000001905"},{"key":"14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.radonc.2015.07.020","article-title":"Neoadjuvant chemoradiotherapy with cisplatin plus vinorelbine versus cisplatin plus fluorouracil for esophageal squamous cell carcinoma: A matched case-control study","volume":"116","author":"Xi","year":"2015","journal-title":"Radiother Oncol"},{"key":"15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ijrobp.2013.04.006","article-title":"Predictors of Postoperative Complications After Trimodality Therapy for Esophageal Cancer","volume":"86","author":"Lin","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature20805","article-title":"Integrated genomic characterization of oesophageal carcinoma","volume":"541","author":"Leuven","year":"2017","journal-title":"Nature"},{"issue":"33","key":"17","first-page":"1754","article-title":"Controversies in the Treatment of Local and Locally Advanced Gastric and Esophageal Cancers","volume":"33","author":"Leichman","year":"2015","journal-title":"J Clin Oncol"},{"key":"18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0003-4975(02)04401-6","article-title":"Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients","volume":"75","author":"Wang","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"19","first-page":"6110","article-title":"A phase III clinical trial of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus","volume":"27","author":"Zhang","year":"2016","journal-title":"Ann Oncol"},{"key":"20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/JCO.1999.17.1.409","article-title":"Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin","volume":"17","author":"Adjei","year":"1999","journal-title":"J Clin Oncol"},{"key":"21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.radonc.2013.09.008","article-title":"Cetuximab in combination with chemoradiotherapy in Chinese patients with non-resectable, locally advanced esophageal squamous cell carcinoma: A prospective, multicenter phase II trial","volume":"109","author":"Yu","year":"2013","journal-title":"Radiother Oncol"},{"key":"22","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijrobp.2014.06.022","article-title":"The Initial Report of Local Control on RTOG 0436: A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Treated Without Surgery","volume":"90","author":"Raben","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ijrobp.2016.08.016","article-title":"Radiation Dose Escalation in Esophageal Cancer Revisited: Contemporary Analysis of the National Cancer Data Base 2004-2012","volume":"96","author":"Baschnagel","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"24","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0360-3016(99)00100-5","article-title":"Does race influence survival for esophageal cancer patients treated on the radiation and chemotherapy arm of RTOG #85-01?","volume":"44","author":"Roach","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy","volume":"20","author":"Kelsen","year":"2002","journal-title":"J Clin Oncol"},{"key":"26","unstructured":"National Comprehensive Cancer. Network (NCCN) Guidelines for Esophageal and Esophagogastric Junction Cancers, version 3.2015. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/. esophageal.pdf. Accessed January 15th, 2016."},{"key":"27","doi-asserted-by":"crossref","first-page":"v50","DOI":"10.1093\/annonc\/mdw329","article-title":"Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Group","year":"2016","journal-title":"Ann Oncol"},{"key":"28","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ijrobp.2004.12.022","article-title":"Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study","volume":"62","author":"Zhu","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ijrobp.2009.02.078","article-title":"Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: is elective nodal irradiation necessary?","volume":"76","author":"Jiang","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"30","first-page":"650","article-title":"Current status and perspectives of radiotherapy for esophageal cancer","volume":"38","author":"Wang","year":"2016","journal-title":"Chin J Oncol"},{"key":"31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ijrobp.2015.07.2284","article-title":"Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized Trials","volume":"93","author":"Ohri","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"32","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.radonc.2009.02.019","article-title":"Evidence-based radiation oncology: oesophagus","volume":"92","author":"Belka","year":"2009","journal-title":"Radiother Oncol"},{"key":"33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.radonc.2016.04.042","article-title":"Does higher radiation dose lead to better outcome for non-operated localized esophageal squamous cell carcinoma patients who received concurrent chemoradiotherapy? A population based propensity-score matched analysis","volume":"120","author":"Chien","year":"2016","journal-title":"Radiother Oncol"},{"key":"34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jtho.2016.10.013","article-title":"Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I\/II Trial","volume":"12","author":"Minsky","year":"2017","journal-title":"J Thorac Oncol"},{"key":"35","doi-asserted-by":"publisher","first-page":"22523","DOI":"10.18632\/oncotarget.8000","article-title":"Is internal target volume accurate for dose evaluation in lung cancer stereotactic body radiotherapy?","volume":"7","author":"Hu","year":"2016","journal-title":"Oncotarget"},{"key":"36","first-page":"853","article-title":"Simulation of dosimetric consequences of 4D-CT-based motion margin estimation for proton radiotherapy using patient tumor motion data","volume":"9","author":"Seco","year":"2014","journal-title":"Phys Med Biol"},{"key":"37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijrobp.2008.12.060","article-title":"Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer","volume":"74","author":"Choi","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"32","key":"38","first-page":"262","article-title":"Impact of respiratory gating using 4-dimensional computed tomography on the dosimetry of tumor and normal tissues in patients with thoracic malignancies","volume":"32","author":"Ahmad","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2016.02.031","article-title":"Effect of contrast enhancement in delineating GTV and constructing IGTV of thoracic oesophageal cancer based on 4D-CT scans","volume":"119","author":"Wang","year":"2016","journal-title":"Radiother Oncol"},{"key":"40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.radonc.2014.12.010","article-title":"Changes in tumour volume and motion during radiotherapy for thoracic oesophageal cancer","volume":"114","author":"Xu","year":"2015","journal-title":"Radiother Oncol"},{"key":"41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijrobp.2006.09.015","article-title":"Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma","volume":"67","author":"Chang","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"42","doi-asserted-by":"crossref","first-page":"iv211","DOI":"10.1093\/annonc\/mdu334.5","article-title":"Interim results of a randomized controlled phase III trial of elective nodal irradiation plus erlotinib combined with chemotherapy for esophgeal squamous cell carcinoma (NCT00686114)","volume":"25","author":"Bian","year":"2014","journal-title":"Ann Oncol"},{"key":"43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2014.11.045","article-title":"Involved field irradiation for the treatment of esophageal cancer: Is it better than elective nodal irradiation?","volume":"357","author":"Yu","year":"2015","journal-title":"Cancer Lett"},{"key":"44","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijrobp.2015.07.015","article-title":"Involved-Field Irradiation vs Elective Nodal Irradiation for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: A Comparative Interim Analysis of Clinical Outcomes and Toxicities (NCT01551589, CSWOG 003)","volume":"93","author":"Lang","year":"2015","journal-title":"Int J Radiat Onco Biol Phys"},{"key":"45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semradonc.2011.09.001","article-title":"Image-guided radiotherapy: has it influenced patient outcomes?","volume":"22","author":"Dawson","year":"2012","journal-title":"Semin Radiat Onco"},{"key":"46","first-page":"705604","article-title":"Image Guidance in Radiation Therapy: Techniques and Applications","volume":"2014","author":"Kataria","year":"2014","journal-title":"Radiol Res Pract"},{"key":"47","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S1470-2045(15)00127-8","article-title":"Neoadjuvant chemoradiation in oesophageal cancer","volume":"16","author":"Adenis","year":"2015","journal-title":"Lancet Oncol"},{"key":"48","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.radonc.2007.10.014","article-title":"Phantom and in-vivo measurements of dose exposure by image-guided radiotherapy (IGRT): MV portal images vs kV portal images vs. cone-beam CT","volume":"85","author":"Wenz","year":"2007","journal-title":"Radiother Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16858","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T19:32:33Z","timestamp":1589139153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,5]]},"references-count":48,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2017,5,23]]}},"alternative-id":["16858","28430590"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.16858","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,5]]}}}